Moraes, R. (2019) “Prevalence of Neuropsychiatric Adverse Effects in HIV Patients Treated with Dolutegravir”, Internal Medicine. Lisboa, Portugal, 26(1), pp. 14–20. doi: 10.24950/rspmi/original/64/1/2019.